Contract research organisations (CROs) provide instrumental
support for the design and execution-based aspects of sponsors’ clinical research. Many pharmaceutical and device
companies recruit CROs to help them overcome a challenging
clinical environment. This environment includes growing R&D
costs, pricing pressures and evolving regulatory guidelines.
Sarah Ray, Senior Research Analyst at Cutting Edge, submits
an editorial on sponsor-CRO relationships, mentioning the
benefits and challenges of collaborating.